Why Goldman Sachs says investors should buy the dip in U.S. tech stocks
Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most valuable U.S. companies at a discount, according to a team of equity strategists at Goldman Sachs Group.
All Eyes on Microsoft Stock Ahead of Earnings; Here’s What Goldman Sachs Expects
Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming the broader market.
DeepSeek is a ‘wake up call’ to buy more stocks, says Goldman Sachs
DeepSeek’s breakthrough is “a wake up call” that adds to market concentration risks, Oppenheimer and team say: a reminder that benefits from any revolutionary technology don’t automatically accrue to big spenders at the start of the adoption cycle, and that competition humbles even the biggest companies.
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Moderna downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded Moderna (MRNA) to Neutral from Buy with a price target of $51, down from $99. The recent product revenue guidance
Moderna down as Goldman Sachs downgrades on revenue outlook
Moderna (NASDAQ:MRNA) traded lower in the premarket on Wednesday after Goldman Sachs downgraded the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook. Goldman's downgrade comes days after the Cambridge,
Moderna stock drops as Goldman Sachs cuts rating
Moderna (NASDAQ:MRNA) shares about 3% ahead of Wednesday market open after Goldman Sachs (NYSE:GS) cut its rating on the stock to Neutral from Buy.
Goldman Sachs Full-Year Profit Rises 68%
Goldman Sachs drove $14.28 billion of profit in 2024, up 68% from the year earlier, reflecting gains in investment banking ...
Goldman Sachs stays bullish on J.B. Hunt stock despite weak 1Q EBIT outlook
Goldman Sachs reiterated its Buy rating and $188.00 price target for J.B. Hunt Transport Services (NASDAQ:JBHT). According to ...
Goldman Sachs 'pleased' with 'strong results' as profit tops Wall Street estimate
Goldman Sachs Group Inc.'s Chief Executive David Solomon said he's "pleased" with the bank's "strong" results after the investment bank handily topped Wall Street estimates for its fourth-quarter ...
Barron's6d
Goldman Sachs Commodity Index Apr 2025
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Yahoo Finance21d
Goldman Sachs Flags Weak Q4 Guidance For Exxon Amid Weak Upstream And Chemical Results
Goldman Sachs analyst Neil Mehta expressed views on ... below their estimate of $1.80 and FactSet consensus of $1.76. The difference is mainly due to weaker-than-expected results in the Upstream ...
Banks Kick Q4 Earnings Season Off With A Bang As CEO Sentiment Improves
Banks such as JPMorgan, Citi, and Goldman Sachs started the earnings season off on a positive note when all beat expectations ...
Bank earnings: JPMorgan, Wells Fargo, Goldman Sachs post beats, and Citi swings to a profit
JPMorgan, Wells Fargo, Goldman Sachs and Citi kicked off earnings season on Wednesday with their December-quarter results.